Aslan Pharmaceuticals Ltd Adr (ASLN) has released an update.
Aslan Pharmaceuticals Ltd Adr has announced the offering of up to $12 million in American Depositary Shares (ADSs), each representing 25 ordinary shares, through an agreement with Jefferies LLC. The ADSs will be issued based on a previously filed registration statement and are fully authorized by the company’s board, ensuring that they will be validly issued and non-assessable upon sale. This move is part of the company’s efforts to increase capital through strategic sales in the open market.
For further insights into ASLN stock, check out TipRanks’ Stock Analysis page.
